Molecule Structure

Scientific Name


Description of the Drug

Droxidopa is a medication used to treat symptomatic neurogenic orthostatic hypotension (nOH) caused by dopamine beta-hydroxylase deficiency, non-diabetic autonomic neuropathy and primary autonomic failure caused by conditions such as Parkinson’s disease.

Source: DrugBank Online – Retrieved 2023-03-10 from

Brand Name(s)


Company Owner(s)

Teva Pharmaceuticals Usa Inc, Alkem Laboratories Ltd, Ajanta Pharma Ltd, Msn Pharmaceuticals Inc, Tris Pharma Inc, Lupin Pharmaceuticals Inc, Celltrion Inc, Sun Pharmaceutical Industries Ltd, Zydus Pharmaceuticals Usa Inc, Upsher Smith Laboratories Llc

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Adrenergic receptor PROTEIN FAMILY AGONIST CHEMBL2331074

Unichem Links

DrugBank DB06262
PubChem: Thomson Pharma 14748940 15220262
PubChem 6989215 92974
Nikkaji J22.085J
BindingDB 50103611
DrugCentral 971
Metabolights MTBLC31524
Brenda 45621 45502
ChemicalBook CB1699324 CB3208010
Guide to Pharmacology 7391
PubChem: Drugs of the Future 12013905
ChEBI 31524
ZINC ZINC000001482049